FGF2 and hepatocellular carcinoma: found that HCC cells cultured in an HSC-conditioned medium activated the PI3K/AKT and MEK/ERK signaling pathways following the combination of E2F3 with the fibroblast growth factor 2 (FGF2) promoter, which increased the growth and metastasis of HCC cells.